159 related articles for article (PubMed ID: 18308803)
1. Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
Fell MJ; Neill JC; Anjum N; Peltola LM; Marshall KM
J Psychopharmacol; 2008 Mar; 22(2):182-6. PubMed ID: 18308803
[TBL] [Abstract][Full Text] [Related]
2. Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats.
Fell MJ; Gibson R; McDermott E; Sisodia G; Marshall KM; Neill JC
Behav Brain Res; 2005 May; 160(2):338-43. PubMed ID: 15863230
[TBL] [Abstract][Full Text] [Related]
3. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC
Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744
[TBL] [Abstract][Full Text] [Related]
4. Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.
Fell MJ; Marshall KM; Williams J; Neill JC
J Psychopharmacol; 2004 Jun; 18(2):149-55. PubMed ID: 15260902
[TBL] [Abstract][Full Text] [Related]
5. Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat.
Kirk SL; Neill JC; Jones DN; Reynolds GP
Eur J Pharmacol; 2004 Nov; 505(1-3):253-4. PubMed ID: 15556160
[TBL] [Abstract][Full Text] [Related]
6. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels.
Roerig JL; Steffen KJ; Mitchell JE; Crosby RD; Gosnell BA
J Clin Psychopharmacol; 2008 Feb; 28(1):21-6. PubMed ID: 18204336
[TBL] [Abstract][Full Text] [Related]
8. No effect of dietary fat on short-term weight gain in mice treated with atypical antipsychotic drugs.
Cope MB; Jumbo-Lucioni P; Walton RG; Kesterson RA; Allison DB; Nagy TR
Int J Obes (Lond); 2007 Jun; 31(6):1014-22. PubMed ID: 17224931
[TBL] [Abstract][Full Text] [Related]
9. Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats.
Snigdha S; Thumbi C; Reynolds GP; Neill JC
J Psychopharmacol; 2008 Jul; 22(5):567-71. PubMed ID: 18208914
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them.
Park S; Sang Mee Hong ; Il Sung Ahn ; Sung Hoon Kim
J Psychopharmacol; 2010 Jul; 24(7):1105-14. PubMed ID: 19965940
[TBL] [Abstract][Full Text] [Related]
11. A model for antipsychotic-induced obesity in the male rat.
Minet-Ringuet J; Even PC; Lacroix M; Tomé D; de Beaurepaire R
Psychopharmacology (Berl); 2006 Sep; 187(4):447-54. PubMed ID: 16783538
[TBL] [Abstract][Full Text] [Related]
12. Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine.
Kalinichev M; Rourke C; Jones DN
Behav Pharmacol; 2006 May; 17(3):289-92. PubMed ID: 16572006
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Raskind MA; Burke BL; Crites NJ; Tapp AM; Rasmussen DD
Neuropsychopharmacology; 2007 Feb; 32(2):284-8. PubMed ID: 16710316
[TBL] [Abstract][Full Text] [Related]
14. Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice.
Yoon S; Noh JS; Choi SY; Baik JH
Biochem Biophys Res Commun; 2010 Mar; 393(2):235-41. PubMed ID: 20117094
[TBL] [Abstract][Full Text] [Related]
15. The effect of ziprasidone on body weight and energy expenditure in female rats.
Park S; Kim MS; Namkoong C; Park MH; Hong JP
Metabolism; 2012 Jun; 61(6):787-93. PubMed ID: 22209671
[TBL] [Abstract][Full Text] [Related]
16. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
[TBL] [Abstract][Full Text] [Related]
17. Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats.
Fell MJ; Neill JC; Rao C; Marshall KM
Psychopharmacology (Berl); 2005 Nov; 182(4):499-507. PubMed ID: 16163524
[TBL] [Abstract][Full Text] [Related]
18. Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment.
Minet-Ringuet J; Even PC; Valet P; Carpéné C; Visentin V; Prévot D; Daviaud D; Quignard-Boulange A; Tomé D; de Beaurepaire R
Mol Psychiatry; 2007 Jun; 12(6):562-71. PubMed ID: 17211438
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors.
Roerig JL; Mitchell JE; de Zwaan M; Crosby RD; Gosnell BA; Steffen KJ; Wonderlich SA
J Clin Psychopharmacol; 2005 Oct; 25(5):413-8. PubMed ID: 16160615
[TBL] [Abstract][Full Text] [Related]
20. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.
Lykkegaard K; Larsen PJ; Vrang N; Bock C; Bock T; Knudsen LB
Schizophr Res; 2008 Aug; 103(1-3):94-103. PubMed ID: 18579346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
